PDGFRA and non-small cell lung carcinoma: This suggests that the lower PKI sensitivity for the NSCLC cell lines is likely due to mutations in genes involved in lung development (e.g., PDGFRA) and axon extension pathway (e.g., DCLK1 or ULK2).